Response to STRIDE: semaglutide in peripheral artery disease and type 2 diabetes – Authors' reply

The Lancet 2026

View at publisher

Authors: Marc P. Bonaca, Joakim Nordanstig, Bernhard H. Ludvik, Alex N. Videmark, Subodh Verma

DOI: 10.1016/s0140-6736(25)02640-6

Cited by: 0

References: 3

Fields of Study & Subjects

Peripheral Artery Disease Management Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins

References 3